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Summary
Grifola frondosa (maitake) is traditionally called 'the king of mushrooms' and 'the hen
of the woods'. Both the fruiting bodies and the mycelium of maitake have been reported
to have antitumor and antiviral activities. Recently, submerged culture processes have been
developed, with the intention of providing opportunities for increased economic exploita-
tion of maitake. Commonly the aim of these processes is to produce extracellular polysac-
charides (EPS), mostly glucans, and to explore their applications, particularly in the cos-
metic industry. A wide variety of EPS with different molecular chain length and chemical
compositions are produced under different culture conditions. In this article, various bio-
logical and physicochemical properties of the EPS of G. frondosa (GF-EPS) are described,
with a view to applications in the area of functional cosmeceuticals. The GF-EPS, together
with GF mycelial extract (GF-MPS), showed antioxidative activity, stimulation of collagen
biosynthetic activity, cell proliferation activity, and inhibitory activity of melanogenesis,
without significant cytotoxicity. These diverse functionalities suggest that both GF-EPS and
GF-MPS can be promising cosmetic ingredients.
Key words: cosmetic ingredients, exopolysaccharide, glucan, Grifola frondosa (maitake), hu-
man dermal fibroblasts, matrix metalloproteinase, skin aging
Introduction
Mushrooms have recently become attractive not only
as functional foods, but also as sources of physiologi-
cally beneficial medicines. For centuries, edible mush-
rooms have been used to treat various health conditions,
including cancer, diabetes, viral infections, and bacterial
infections (1–5). Polysaccharides derived from mush-
rooms that have potent antitumor activities in vitro have
been shown to stimulate the host immune system in ani-
mal studies. In recent clinical trials, medicinal mushrooms,
or polysaccharides extracted from them, have been shown
to extend the survival of cancer patients and to improve
their quality of life (6,7).
Recently, mushroom polysaccharides have found ap-
plications beyond the pharmaceutical area. Due to their
ability to accelerate collagen biosynthesis and to provide
photoprotection, they have found applications as func-
tional materials within the cosmetic industry. The poly-
saccharides of Grifola frondosa have good potential in this
area (8,9).
G. frondosa (maitake) is a basidiomycete belonging
to the order Polyporales, and the family Meripilaceae.
The fruiting body and also the mycelium obtained from
submerged liquid culture have been reported to contain
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useful antitumor polysaccharides (10–12). Maitake has
been frequently used to treat spleen and stomach ail-
ments, to calm the nerves and the mind, and to treat
hemorrhoids. Dry maitake has been used in the produc-
tion of health foods, including teas, whole powders, pow-
ders of hot water extracts, granules, and drinks (13).
Many investigators have tried to cultivate mush-
rooms on solid artificial media for fruiting body forma-
tion in order to obtain bioactive polysaccharides (14–18).
However, this method does not guarantee a standard-
ized product, since the polysaccharide composition var-
ies from batch to batch. As a result, recent attention has
been paid to the use of submerged culture of higher
fungi for the production of mycelial biomass and bio-
active products, particularly extracellular polysacchari-
des (EPS) (19–25).
Although several investigators have reported anti-
tumor activities for different polysaccharide extracts ob-
tained from the fruiting bodies of G. frondosa, the biolo-
gical activities of EPS prepared from submerged cultures
of this fungus have received much less attention (26–33).
Even so, these EPS have been shown to have several phy-
siologically important activities (9,10). However, studies
have focused mainly on medicinal uses, such as anti-
tumor activity and immunostimulation, while relatively
little work has been done to investigate the application
of mushroom polysaccharides in cosmetics. There are
two main fields of potential application in this area,
namely as antioxidants to combat the effects of reactive
oxygen species and as stimulators of tissue repair after
damage, especially UV damage.
Reactive oxygen species (ROS), such as hydroxyl and
superoxide radicals, are produced by sunlight, ultravio-
let radiation, chemical reactions and metabolic processes.
They have a wide variety of pathological effects on cellu-
lar processes (34). Superoxide radical is one of the strong-
est free radicals in cellular oxidation reactions because,
once it forms, it further produces various kinds of cell-
-damaging free radicals and oxidizing agents (35,36).
Free radicals are molecules or parts of molecules with
unpaired reactive electrons, and can be generated by the
metabolic processing of oxygen. They are hostile and
damaging to cells and their functions. They can also ini-
tiate a chain reaction, with the multiplication of new
free radicals. The damage that they cause includes tissue
loosening, genetic damage and the promotion of disease
and aging (37). Free radicals are implicated in many dis-
eases such as heart disease, cancer, arthritis, and the ag-
ing process itself. To combat these free radicals the body
needs antioxidants (35). The antioxidant properties of
four specialty mushrooms, including maitake, were stu-
died by Mau et al. (38). Almost all extracts of the fruit-
ing bodies that they examined showed antioxidant activ-
ity; the maitake extract showed about 40 % free radical
inhibition activity.
Ultraviolet (UV) irradiation damages human skin and
causes premature skin aging (photoaging) through the
activation of matrix metalloproteinases (MMPs), which
are responsible for the degradation of collagen, gelatin
and other components of the extracellular matrix (ECM)
(39). Several investigators elucidated the influence of
UVA irradiation on the stimulation of interstitial colla-
genase and gelatinase mRNA and their corresponding
proteins in cultured human dermal fibroblasts (HDF)
(40,41). Some types of polysaccharides have been sug-
gested to play a role during the early stages of healing
of a variety of connective tissues, for example in cell
proliferation and in the synthesis of matrix components
(42,43). Hyaluronan (HA) is a representative biomaterial
for this use (44). The importance of HA has been exten-
sively described for the homeostasis of connective tis-
sues during embryogenesis and aging and its role in tis-
sue repair. Croce et al. (44) elucidated the effect of exoge-
nous HA on the synthesis of total protein and collagen
in HDF. There were strong indications that a relatively
high concentration of HA in the extracellular space, such
as during development and in the first phases of tissue
repair, would partially limit the deposition of the extra-
cellular matrix, and of collagen in particular (44). For
this reason, HA has been widely used as a cosmetic in-
gredient for a long time. Other types of polysaccharides
have been used as alternative ingredients for enhancing
collagen biosynthesis in skin cells (45,46). EPS from G.
frondosa may also have a potential for this application.
In our search for functional cosmetic ingredients
from mushrooms, our group has produced several kinds
of EPS in submerged culture of G. frondosa and investi-
gated their biological activities, including antioxidative
and free radical scavenging activities, as well as their
ability to stimulate the proliferation of human dermal
fibroblasts and also the biosynthesis of collagen in these
cells. In this paper, we describe the production, charac-
terization, biological activities, and application of EPS




G. frondosa HB0071 was maintained on potato dex-
trose agar (PDA) slants. Unless otherwise specified, slants
were incubated at 27 °C for 5 days and then stored at 4
°C. The seed culture was grown in a 250-mL flask con-
taining 50 mL of glucose medium. This medium con-
tained (in g/L): glucose 30, yeast extract 6, polypeptone
2, MgSO4·7H2O 0.5, K2HPO4 0.5, and MnSO4·5H2O 0.2. It
was incubated at 27 °C on a rotary shaker at 120 rpm for
5 days.
Submerged mycelial cultures for EPS production
The other seed cultures were performed in a 500-mL
flask containing 100 mL of the media after inoculating
with 3 % (by volume) of the seed culture, and then culti-
vated at 25 °C in a 5-litre stirred-tank bioreactor (KoBio-
Tech Co., Incheon, Korea) or in a 5-litre airlift fermentor
(Best Korea Co. Ltd., Daejeon, Korea). Fermentations were
conducted at 25 °C, with an aeration rate of 1.16 vvm, an
agitation speed of 166 rpm, a pH of 5.06, and a working
volume of 3 L.
Preparation of EPS
The fermentation broth was centrifuged at 8000 × g
for 20 min, and the resulting supernatant was filtered
through Whatman filter paper No. 2 (Whatman Interna-
tional Ltd., Maidstone, UK). The filtrate was mixed with
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four volumes of absolute ethanol, stirred vigorously and
left overnight at 4 °C. The precipitated EPS was collected
by centrifugation at 8000 × g for 10 min. The superna-
tant was discarded. The residue was reprecipitated with
four volumes of ethanol and the precipitate of purified
EPS was freeze-dried in a lyophilizer.
Preparation of mycelial polysaccharides
For isolation of mycelial polysaccharides, mycelial
cells were obtained by filtration of culture broths. They
were washed 3 times with distilled water then suspen-
ded in distilled water. The solutions were heated for 6 h
in an autoclave at 121 °C to extract heat-stable mycelial
polysaccharides, followed by filtration. The filtrates were
then put through a process of ethanol precipitation, dial-
ysis, and then the mycelial polysaccharide preparations
were freeze-dried in a lyophilizer.
Estimation of mycelial growth and EPS production
Mycelial growth was estimated by the dry mass of
the mycelium pellets after repeated washing with dis-
tilled water and drying overnight at 70 °C to a constant
mass. EPS production was estimated by the dry mass of
the lyophilized EPS precipitate. To measure the residual
glucose, the filtrate was analyzed by high performance
liquid chromatography (HPLC) using a Sugar-Pak column
(300×6.5 mm, Waters Co., Milford, MA, USA) equipped
with an evaporative light-scattering detector (ELSD, All-
tech Associates, Deefield, IL, USA).
Evaluation of the mycelial morphological and
rheological properties
The morphological properties of the mycelia were
evaluated using an image analyzer (WINA Tech Co.,
Ansan, Korea) with software coupled to a light micro-
scope through a charged coupled device (CCD) camera
(Toshiba Co., Japan). The samples were fixed with an
equal volume of fixative (prepared by mixing 13 mL of
40 % formaldehyde and 5 mL of glacial acetic acid into
200 mL of 50 % ethanol). Each fixed sample (0.1 mL)
was transferred to a slide, air dried and stained with
methylene blue (0.3 g of methylene blue, 30 mL of 95 %
ethanol in 100 mL of water) (47). Rheological measure-
ments using Brookfield programmable LVDVII+ digital
viscometer (Brookfield Engineering Laboratories Inc.,
Stoughton, MA, USA) fitted with a small sample adap-
ter were also performed on samples collected from the
bioreactor at regular intervals.
EPS analysis of carbohydrates and amino acids
The total sugar content of EPS was determined by
the phenol-sulphuric acid method using glucose as the
standard (48). The sugar composition was analyzed by
HPLC (Waters 2695 Separations Module, Waters Co.,
Milford, MA, USA) with a Sugar-Pak 1 column and an
ELSD detector. The total protein was determined by the
Lowry method with bovine serum albumin as the stan-
dard (49). The composition of amino acids was deter-
mined by HPLC with an AccQ·Tag Amino Acid Analy-
sis column (150×3.9 mm, Waters Co., Milford, MA, USA)
and a photoarray detector (996, Waters Co., Milford,
MA, USA).
EPS molecular mass determination
The molecular mass of EPS was estimated on the
basis of the calibration curve made by the HPLC system
with a Shodex OHpak KB-804 column (300×0.8 mm,
Showa Denko K.K., Tokyo, Japan) using distilled water
as a mobile phase (column temperature 50 °C; flow rate
0.8 mL/min; injection volume 20 µL). The eluate was
monitored by an ELSD detector. The column was stan-
dardized with dextrans of diverse molecular masses (Po-
lymer Standards Service Inc., Silver Spring, MD, USA).
Superoxide dismutase (SOD) activity
Superoxide dismutase (SOD) activity was measured
using the xanthine–xanthine oxidase system as a source
of superoxide and nitroblue tetrazolium (NBT) as a sca-
venger for this radical. One unit of SOD activity was de-
fined as the amount of enzyme causing 50 % inhibition
of the initial rate of reduction of NBT. SOD activity was
determined as described by Beauchamp and Fridovich
(50) by measuring percent inhibition of NBT reduced by
SOD. A volume of 1 mL of 0.3 mM xanthine, 500 mL of
0.6 mM EDTA, 500 mL of 0.15 mM NBT and 100 mL of
polysaccharides were mixed on the plate. After adding
xanthine oxidase, the formazan produced was measured
spectrophotometrically at 560 nm. The plates were incu-
bated for 20 min at 37 °C. Experiments were performed
in triplicate.
Culture of human dermal fibroblasts (HDF)
HDF, isolated from human neonatal foreskin, were
purchased from Modern Tissue Technologies Inc. (Seoul,
Korea). They were cultured on Dulbecco’s modified Ea-
gle’s medium/Ham’s F-12 nutrient mixture (DMEM/
F-12; 3:1 by volume, Sigma) at 37 °C in a humidified at-
mosphere containing 5 % CO2, 10 % fetal bovine serum
(FBS), penicillin (100 IU/mL), and streptomycin (100
mg/mL). Fibroblast cultures were subcultured by trypsi-
nization and used between the sixth and tenth passages.
UVA irradiation
HDF (1.5×105/well) were seeded into 35-mm diame-
ter plates (CORNING®, Corning Inc., NY, USA) and cul-
tured overnight. Prior to irradiation, when cells were
70–80 % confluent, they were washed twice with phos-
phate buffered saline (PBS, HyClone Laboratories, Lo-
gan, UT, USA). A UVA simulator (Jhonsam Inc., Seoul,
Korea), filtered for the emission of UVA (320–400 nm),
was used at a tube-to-target distance of 15 cm. The dose
of UVA radiation, determined with a UV radiometer (In-
ternational Light Inc., Newburyport, MA, USA) was set
at 6.3 J/cm2. After irradiation, fresh serum-free media
containing EPS at different concentrations were added
to cells at 37 °C for 24 h.
Measurement of free radical scavenging activity
HDF were cultured on Dulbecco’s modified Eagle’s
medium (DMEM) containing 10 % fetal bovine serum
(FBS), penicillin (100 IU/mL), and streptomycin (100
mg/mL), and then 2×105 cells were added to each well
of a 24-well microtiter plate. The cells were maintained
in a humidified atmosphere of 5 % CO2 and 95 % air, at
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37 °C. Analyses of confluent fibroblast cultures were
carried out at 6–10 passages of subcultivation. The cul-
tured fibroblast cells were treated with 0.5 % polysac-
charides for 1 h before UV irradiation. Immediately before
UVA irradiation, the medium was replaced by phospha-
te buffered saline (PBS). The UVA irradiation dose was
360 mJ/cm2. A non-fluorescent compound, 2’,7’-dichlo-
rodihydrofluorescein diacetate (DCF-DA), was able to
react with free radical compounds, especially with hy-
drogen and to generate a fluorescent product. Cells were
loaded with 5 mM DCF and 2 % Pluronic F-127 in HCSS
solution (120 mM NaCl, 5 mM KCl, 1.6 mM MgCl2,
2.3 mM CaCl2, 15 mM glucose, 20 mM HEPES and 10 mM
NaOH), incubated for 20 min at 37 °C and then washed
three times with HCSS solution. The fluorescence signal
of DCF (lex=490 nm; lem=510 nm), the oxidation product
of DCF-DA by free radicals, was then analyzed by flow
cytometry (Becton Dickinson, NJ, USA) (51). Experi-
ments were performed in triplicate.
Activity on the proliferation of fibroblasts
Mouse fibroblasts NIH 3T3 were cultured on DMEM
containing 10 % FBS and then 2×105 cells were added to
each well of a 24-well microtiter plate. After addition of
10 % (by mass per volume) of polysaccharide solution
into each well, the 24-well plate was maintained at 37
°C in a CO2 incubator for 2 days. After the cultivation
was completed and DMEM removed, 60 mL of 0.5 %
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoli-
um bromide) and 500 mL of fresh DMEM were added to
each well. The plate was maintained in a CO2 incubator
for 2 h to allow formazan formation. The quantity of
formazan produced can be regarded as an indicator of
cell density or viability. After dissolving the formazan in
dimethyl sulfoxide (DMSO), the absorbance at 565 nm
was measured with a microplate reader (Multiskan Ex,
Thermo Electron Co., Finland). The proliferation of fibro-
blasts was evaluated by comparing the absorbance with
that of the untreated control.
Activity on collagen biosynthesis
Collagen from fibroblasts was quantified by the Si-
rius Red method (52). Human dermal primary fibroblast
p16 was seeded in 1-mL aliquots, in DMEM containing
10 % FBS, to give a density of 1×105 cells per well in a
24-well plate. After a 24-hour incubation at 37 °C, the
medium was replaced with 1 mL of DMEM containing
10 % (by mass per volume) of polysaccharide solution.
After 48 h, the cell culture supernatant and the cell ex-
tracts obtained by rapid freezing and thawing were
dried onto the plate. The plates were incubated at 37 °C
overnight (humidified) and then kept for 24 h at 37 °C.
Each well was filled with 1 mL of 0.1 % (by mass per
volume) Sirius Red F3BA in saturated picric acid and
the samples were stained for 1 h at room temperature.
The plate was washed five times with 2 mL of 10 mM
HCl, each wash lasting 10 s. The collagen-bound stain
was then extracted with 2 mL of 0.1 M NaOH for 5 min.
Absorbance was then read at 565 nm in a microplate
reader. Experiments were performed in triplicate.
RNA isolation and RT-PCR
RNA was extracted using an RNeasy Mini Kit (Qia-
gen, Maryland, USA) according to the supplier’s instruc-
tions. First, a reverse-transcriptase polymerase chain re-
action (RT-PCR) was performed to synthesize cDNA us-
ing an Omniscript RT Kit (Qiagen, Hilden, Germany) ac-
cording to the manufacturer’s instructions. PCR was
then performed with each cDNA of the matrix metallo-
proteinase 1 (MMP-1), b-actin fragments, primers, and








The primer sets yielded PCR products of 237 and
248 bp for MMP-1 and b-actin, respectively. Reactions
were carried out in an automatic heat-block DNA ther-
mal cycler (ASTEC PC801, ASTEC Inc, Tokyo, Japan) for
25 cycles: denaturation for 30 s at 94 °C; annealing for
30 s at 50 °C; extension for 60 s at 72 °C. PCR products
were electrophoresed on a 1.5 % agarose gel in TAE (40
mM Tris acetate, 1 mM EDTA) and visualized by ethi-
dium bromide staining. The level of expression of each
mRNA gene was expressed as the ratio of the intensity
of each gene PCR product to the corresponding b-actin
PCR product (this being used as a reference molecule
for measuring mRNA stability) and normalized to the
control sample.
Cytotoxicity assay
The cell viability was determined by the modified
method of Mosmann (53) using the MTT (3-[4,5-dime-
thylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay,
which involves the formation of a dark blue formazan
product by mitochondrial dehydrogenase. HDF were cul-
tured on DMEM/F-12 containing 10 % (by volume) FBS
and then 2×104 cells were added to each well of a 96-
-well microtiter plate. After addition of EPS at different
concentrations into the different wells, the 96-well plate
was maintained at 37 °C for 24 h in a CO2 incubator. Af-
ter cultivation was completed and DMEM/F-12 removed,
12 µL of 0.5 % MTT and 100 µL of fresh DMEM were
added to each well. The plate was placed in the CO2 in-
cubator for 4 h to allow formazan formation. The quan-
tity of formazan produced can be regarded as an indica-
tor of cell density or viability. After dissolving formazan
in 100 µL of acid-isopropanol (0.04 M HCl in isopropa-
nol), the absorbance at 570 nm was measured with a mi-
croplate reader (Model ELX 800, BIO-TEK Inc., Winoo-
ski, VT, USA). The results obtained were calculated from
three sets of experiments and are presented as a percent-
age of control values.
Enzyme-linked immunosorbent assay (ELISA)
The expression level of MMP-1 was assayed by an
enzyme-linked immunosorbent assay (ELISA). HDF (2×104
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cells/well) were seeded into 48-well plates and cultured
overnight. The culture media were replaced with DMEM/
F-12 containing EPS at different concentrations. After
24-hour incubation, samples of the supernatants were
transferred into a 96-well plate and a volume of coating
buffer (Na2CO3 1.59 %, NaHCO3 2.93 %, NaN3 0.20 %,
MgCl2 1.02 %, pH=9.6) equal to the sample volume was
added to each well. Plates were incubated for 24 h. The
supernatants were removed and the coated well was
washed three times with PBS containing 0.05 % Tween
20 (PBST) followed by blocking with 3 % bovine serum
albumin in PBS for 1 h at 37 °C. After washing three
times with PBST, 50 µL of 1/1000 diluted primary anti-
body (Ab), Ab-5 in PBST, were added into each well and
incubated for 60 min. After washing the wells with
PBST three times, 50 µL of 1/1000 diluted secondary Ab,
anti-mouse IgG conjugated with alkaline phosphatase in
PBST, were added and incubated for 60 min. After wash-
ing five times with PBST, 100 µL of 1mg/mL of pNPP
(p-nitrophenylphosphate) in a diethanolamine buffer were
added. The absorbance was measured at 405 nm after 30
min. Finally, cytotoxicity of the supplemented chemicals
was measured by the MTT assay.
Inhibitory effect on melanin biosynthesis
First, the inhibitory effect of GF-glucans on melanin
biosynthesis was investigated by measuring the inhibi-
tion of tyrosinase (a key enzyme in melanin biosynthe-
sis) activity, as outlined by Kageyama et al. (54). Second,
the melanin content was determined using a combined
method outlined by Oka et al. (55) and Kageyama et al.
(54). Mouse B16 melanoma cells were cultured in Eagle’s
minimal essential medium containing 10 % FBS, 100 U/mL
of penicillin, 100 mg/mL of streptomycin, and 250 ng/mL
of fungizone in a humidified atmosphere containing 5 %
CO2 at 37 °C. The cells from a subconfluent monolayer
in a 10-cm culture dish were solubilized in 150 mL of 1
M NaOH, incubated at 80 °C for 2 h, and vortexed to
solubilize the melanin. The absorbance of the solution
was measured at 400 nm and was compared with a
standard curve obtained using known concentrations of
synthetic melanin (Sigma). The melanin content was ex-
pressed as mg/mg of protein.
Statistical analysis
All experiments were performed in triplicate. Data
are presented as mean ± standard error (SE). Experimen-
tal results were analyzed statistically using Student’s
t-test (SigmaPlot 2000). P values less than 0.05 were con-
sidered to be statistically significant.
Results and Discussion
Submerged culture of Grifola frondosa
The fruiting body, mycelial formation on an agar
plate, and typical mycelial morphology of G. frondosa in
a stirred-tank bioreactor are presented in Fig. 1. One of
the advantages of mycelial culture of G. frondosa is that
it takes only 3.5 days to reach maximum mycelial bio-
mass (24.8 g/L) and EPS production (7.2 g/L) in a stir-
red-tank bioreactor (Fig. 2). Note that many other ma-
crofungi require up to 10 days to reach maximum mycelial
biomass and EPS concentrations when grown in sub-
merged cultures (56,57). G. frondosa therefore offers the
potential for higher productivities of EPS in submerged
culture. The optimum culture conditions for both my-
celial biomass and EPS are presented in Table 1.
We investigated the growth and EPS production by
G. frondosa in an airlift bioreactor since this type of bio-
reactor is often better for mycelial growth than stirred
tank bioreactors, due to lower shear forces. However, the
maximum concentrations of mycelial biomass (10 g/L)
and EPS (4.53 g/L) obtained in the airlift bioreactor were
lower than those in the stirred-tank bioreactor. It is pro-
bable that the stirred-tank bioreactor not only provided
better mixing, but also promoted the formation of the
desired morphology. Even when growth conditions are
quite similar, the mycelium grows as feather-like myce-
lial clumps in the stirred tank bioreactor and as compact
pellets in the airlift bioreactor (27).
In fact, our previous study of the morphology of
growth in stirred tank bioreactors showed that G. fron-
dosa mainly forms pellets with high hairiness, with pel-
let size increasing rapidly from the beginning of the fer-
mentation and reaching a maximum value at day 4,
which corresponded to the time of maximum biomass
and EPS concentrations (27). After this period, the core
region became denser and larger, due to a lack of nutri-
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Fig. 1. Fruiting body (a), mycelial growth (b) on PDA medium (at day 3), and mycelial pellet growth (c) in a stirred-tank bioreactor
(at day 6) of Grifola frondosa HB0071
(a) (b) (c)
ent and oxygen supply. Later, the larger pellets broke
into several smaller pellets, but without significant hy-
phal fragmentation, since there was no significant in-
crease in the concentration of free mycelia. The culture
pH, aeration rate, and hydrodynamic behavior affected
the growth morphology and the changes during the cul-
ture: compact pellets were formed under low aeration,
whereas freely suspended mycelial growth was obtained
under high aeration. Maximum mycelial biomass and
polysaccharide levels were achieved when the biomass
grew as loose mycelial clumps with high hairiness.
Our observations about the morphology of growth
in our previous study prompted us to investigate the
rheology of the EPS in the present work. Fig. 3 shows
that an aqueous solution of GF-glucan demonstrated a
pseudoplastic flow behavior, and the viscosity of GF-EPS
was similar to mannans and higher than hyaluronic acid.
Characterization of GF polysaccharides
Five polysaccharide preparations were characterized,
namely a mycelial extract (GF-MPS) and the top and
bottom fractions of filtrate precipitates obtained after the
submerged culture of G. frondosa in two different media
(glucose medium and PMP medium, the latter consist-
ing of potato dextrose broth 24 g/L, malt extract 10 g/L,
and peptone 1 g/L). The EPS preparations had diverse
molecular masses, ranging from 470 to 1650 kDa, and
their individual biological activities were different (8).
These EPS preparations contained 66–94 % polysaccha-
ride and 6–34 % protein. The protein moiety of the GF-
-EPS contained 16 kinds of amino acids, the main ones
being threonine, alanine, valine and glutamine; the car-
bohydrate moiety contained four sugars, the main ones
being glucose and galactose.
Cytotoxicity of GF polysaccharides
Cytotoxicity was evaluated by measuring the mito-
chondrial dehydrogenase activity in cells. This assay is
based on the active transport of MTT (a tetrazolium salt)
into the cell, which is then reduced to a formazan by-
product by mitochondrial dehydrogenases (53). This test
was used to investigate the effect of different doses of
EPS on the viability of human dermal fibroblasts. Cells
were incubated with EPS concentrations of 1–4 % for 24
h. In all groups, the EPS did not significantly affect cell
viability nor did it cause morphological changes (Fig. 4).
In fact, the cell viabilities were higher after the treat-
ments with either GF-EPS or GF-MPS than they were
with β-glucan and sodium hyaluronate, compounds that
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Table 1. Optimum culture conditions of Grifola frondosa for the
production of mycelial biomass and EPS
Items Condition
Carbon source Glucose, 30 g/L
Nitrogen source Yeast extract, 6 g/L
Inoculum size 3 % (by volume)
pH and temperature pH=5.06* and 25 °C
Aeration rate 1.16 vvm*
Agitation intensity 166 rpm*
*Conditions optimized by self-directing optimization method
Shear rate/s–1














































Fig. 3. Viscosity (a) and shear rate versus shear stress (b) of the
GF-EPS solution
Time/h



























































Fig. 2. Typical time profiles of mycelial biomass and exopoly-
saccharide production in submerged culture of Grifola frondosa
in a 5-litre stirred-tank bioreactor, under optimized conditions
(controlled pH=5.06, aeration volume 1.16 vvm, agitation speed
166 rpm)
have been widely used as cosmeceuticals. Therefore, with-
in the dosage range tested, human dermal fibroblasts
treated with EPS did not exhibit any cytotoxicity.
Antioxidant activity of GF polysaccharides
The antioxidant activities of the GF-EPS and GF-MPS
were investigated by measuring the superoxide scaveng-
ing activity. As shown in Fig. 5, both GF-EPS and GF-
-MPS had high antioxidant activity, in a dose-dependent
manner. The GF-MPS showed higher activity (89 % at
0.2 %) than that of GF-EPS (50 % at 0.2 %). However,
this activity was lower than (-)-epigallocatechin-3-gallate
(EGCG), a main component of green tea extract (89 % at
0.001 %). Antioxidative activity of mushroom polysac-
charides has been found in other species (58–61).
Free radical scavenging activity of GF
polysaccharides after UV irradiation
At a concentration of 0.2 % (by mass per volume),
both GF-EPS and GF-MPS decreased free radical levels
(formed after UV irradiation) by approximately 20 %
(Fig. 6). However, this is a relatively low free radical
scavenging activity when compared to the activities of
green-tea extract and vitamin C, which are potent free
radical scavengers (8). Liu et al. (62) studied the free rad-
ical scavenging activity of various mushroom polysac-
charides of diverse forms (e.g. mycelium extract, fruiting
body extract, and culture filtrate). Five mushroom po-
lysaccharide extracts and a protein-bound polysaccharide
exhibited significant superoxide and hydroxyl radical sca-
venging activities. Kim and Kim (63) reported that a hot-
-water extract of the fruiting body of Ganoderma lucidum
provided radioprotection and antioxidant defense against
oxygen radical-mediated damage after metal-catalyzed
Fenton reactions and UV irradiation. In fact, a water-sol-
uble polysaccharide, isolated from the fruiting body of
G. lucidum, was as effective as the hot-water extract in
protecting against hydroxyl radical-induced DNA strand
breaks, indicating that the polysaccharide compound is
associated with the protective properties (63).
Effect of GF polysaccharides on UVA-mediated
MMP-1 expression
In the present study, in order to estimate the effect
of EPS on matrix metalloproteinase 1 (MMP-1) expres-
sion in UVA-irradiated HDF (6.3 J/cm2), the ELISA me-
thod was used to quantify MMP-1 in the culture me-
dium of HDF. The treatment of UVA-irradiated HDF
with both GF-EPS and GF-MPS, both at concentrations
of 0.2 % (by mass per volume), decreased the expression
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Fig. 4. The cytotoxicity of GF-EPS and GF-MPS produced by
submerged culture of G. frondosa HB0071 with reference to yeast
b-glucan and sodium hyaluronate. The cell viability is expres-
sed as a percentage of viable cells in comparison with the via-
ble cells in the reference compounds. The cytotoxicity is signifi-




































Fig. 5. Superoxide radical scavenging activity of GF-EPS and
GF-MPS produced by submerged culture of G. frondosa HB0071.
EGCG was used as a positive control. The activity is expressed
as a percentage increase in comparison with that of control. The

























































Fig. 6. Free radical scavenging by GF-EPS and GF-MPS in the
UV irradiated human fibroblast. The activity is significant
(p<0.05) and the values are mean ± S.E.
of MMP-1 by 20 and 40 %, respectively (Fig. 7). Surpris-
ingly, the inhibitory effect at an EPS concentration of 100
µg/mL was significantly higher than that of trans-reti-
noic acid (tRA), which is widely known as an inhibitor
of UVA-induced MMPs (9). Fisher et al. (64) reported that
tRA, applied to human skin, inhibits subsequent activa-
tion of activator protein (AP)1, a step that is essential for
transcription of MMPs, and the induction of MMPs by
UVA irradiation. Several investigators have reported that
microbial glucan stimulated macrophage release of wound
growth factors, which modulated fibroblast collagen bio-
synthesis (65,66). Recently, Kougias et al. (67) have re-
ported the presence of at least two glucan binding sites
on normal human fibroblasts.
Effect of GF polysaccharides on cell proliferation
activity
The capability of GF-EPS and GF-MPS to stimulate
proliferation of skin cells was investigated at concentra-
tions of 0.05–0.2 % (by mass per volume). As shown in
Fig. 8, both GF-EPS and GF-MPS stimulated the prolifer-
ation of fibroblasts by approximately 21–25 %, in a dose-
-dependent manner. Their activities were higher than that
of β-glucan, but lower than that of epidermal growth
factor (EGF). Other useful materials, such as biscoclau-
rine alkaloid cepharanthine and sodium lauryl sulfate (SLS),
have been reported for fibroblast proliferation (68–70).
Collagen biosynthesis stimulating activity of GF
polysaccharides
In the present study, the treatment of fibroblasts with
GF-MPS, at a concentration of 0.2 % (by mass per vol-
ume), stimulated an increase of 53 % in the biosynthesis
of collagen, while GF-EPS and yeast β–glucan caused
lower stimulation levels (Fig. 9). Fig. 10 shows the effect
of GF-EPS on the expression of type I collagen mRNA in
human dermal fibroblasts. Fibroblasts were cultured with
different doses of GF-EPS for 12 h and their expression
levels were compared with the control. GF-EPS treat-
ment of cells led to increased mRNA levels, although
the levels were lower than those in cells treated with
ascorbic acid.





























Fig. 7. MMP-1 (collagenase) inhibitory activity of GF-EPS and
GF-MPS produced by submerged culture of G. frondosa HB0071.
Yeast b-glucan and 1,10-phenanthroline were used as positive
controls. The activity is expressed as a percentage increase in
comparison with that of control. The activity is significant (p<0.05)











































Fig. 9. The stimulation of type I collagen biosynthesis with GF-
-EPS and GF-MPS produced by submerged culture of G. fron-
dosa HB0071. Yeast b-glucan and L-ascorbic acid were used as
positive controls. The activity is significant (p<0.05) and the va-

















































Fig. 8. The stimulation of cell proliferation by GF-EPS and GF-
-MPS produced by submerged culture of G. frondosa HB0071.







Fig. 10. Effect of GF-EPS on the expression of type I collagen
mRNA in human dermal fibroblast. Fibroblasts were cultured
with varying doses of GF-EPS for 12 h and compared with the
control. Total RNA extracted from human dermal fibroblast was
analyzed by RT-PCR. 1) Control, 2) 200 mM ascorbic acid, 3) 0.2
% GF-EPS, 4) 0.1 % GF-EPS, 5) 0.05 % GF-EPS
Inhibitory effect of GF polysaccharides on melanin
biosynthesis
Tyrosinase controls the first and the rate-limiting step
of melanogenesis, and is therefore the key enzyme of this
cascade. Consequently, it is the target of different effec-
tors that regulate melanin synthesis. In this study, GF-
-MPS inhibited the tyrosinase activity by 30 % at a con-
centration of 0.04 %, whereas GF-EPS showed no signifi-
cant effect. The positive control, kojic acid, caused 50 %
inhibition at a concentration of 0.04 % and the effect was
dose-dependent (Fig. 11). Treatment of B16 mouse mela-
noma cells with GF-EPS and GF-MPS resulted in the in-
hibition of melanogenesis by 25 and 17 %, respectively
(Fig. 12). These results imply that the inhibitory effect of
GF-EPS on melanogenesis does not result from a direct
inhibition of tyrosinase activity but rather from a more
complicated phenomenon mediated by cellular signal-
ing events. The inhibitory effect of GF-EPS (0.2 % treat-
ment) was similar to arbutin. Arbutin is a popular active
substance, originating from natural plants, which can
whiten and lighten the skin. It can infiltrate into the skin
quickly without affecting cell multiplication and effec-
tively prevent the activity of tyrosinase in the skin. Con-
sequently, it also prevents the formation of melanin
(71,72).
Conclusion
Our results suggest that GF polysaccharides obtained
from a mycelial culture broth of the new isolate of G.
frondosa are a potential candidate to reduce MMP activ-
ity in the skin after solar stimulation. In the future, com-
binations of other natural compounds may be envisaged
for more efficient photoprotection and a further study
for elucidating overall biological functions of the poly-
saccharides in vivo should be performed.
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